Frontiers in Medicine (Feb 2024)
Frequency and impact on renal transplant outcomes of urinary tract infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species
- Jakob E. Brune,
- Michael Dickenmann,
- Daniel Sidler,
- Laura N. Walti,
- Déla Golshayan,
- Oriol Manuel,
- Oriol Manuel,
- Fadi Haidar,
- Dionysios Neofytos,
- Aurelia Schnyder,
- Katia Boggian,
- Thomas F. Mueller,
- Thomas Schachtner,
- Nina Khanna,
- Stefan Schaub,
- Stefan Schaub,
- Caroline Wehmeier,
- the Swiss Transplant Cohort Study,
- Patrizia Amico,
- John-David Aubert,
- Adrian Bachofner,
- Vanessa Banz,
- Sonja Beckmann,
- Guido Beldi,
- Christoph Berger,
- Ekaterine Berishvili,
- Annalisa Berzigotti,
- Pierre-Yves Bochud,
- Sanda Branca,
- Heiner Bucher,
- Anne Cairoli,
- Emmanuelle Catana,
- Yves Chalandon,
- Sabina De Geest,
- Sophie De Seigneux,
- Michael Dickenmann,
- Joëlle Lynn Dreifuss,
- Michel Duchosal,
- Thomas Fehr,
- Sylvie Ferrari-Lacraz,
- Jaromil Frossard,
- Christian Garzoni,
- Déla Golshayan,
- Nicolas Goossens,
- Fadi Haidar,
- Jörg Halter,
- Dominik Heim,
- Christoph Hess,
- Sven Hillinger,
- Hans Hirsch,
- Patricia Hirt,
- Linard Hoessly,
- Günther Hofbauer,
- Uyen Huynh-Do,
- Franz Immer,
- Michael Koller,
- Andreas Kremer,
- Christian Kuhn,
- Bettina Laesser,
- Frédéric Lamoth,
- Roger Lehmann,
- Alexander Leichtle,
- Oriol Manuel,
- Hans-Peter Marti,
- Michele Martinelli,
- Valérie McLin,
- Katell Mellac,
- Aurélia Merçay,
- Karin Mettler,
- Nicolas Müller,
- Ulrike Müller-Arndt,
- Beat Müllhaupt,
- Mirjam Nägeli,
- Graziano Oldani,
- Manuel Pascual,
- Jakob Passweg,
- Rosemarie Pazeller,
- Klara Posfay-Barbe,
- David Reineke,
- Juliane Rick,
- Anne Rosselet,
- Simona Rossi,
- Rössler,
- Silvia Rothlin,
- Frank Ruschitzka,
- Thomas Schachtner,
- Stefan Schaub,
- Alexandra Scherrer,
- Dominik Schneidawind,
- Aurelia Schnyder,
- Macé Schuurmans,
- Simon Schwab,
- Thierry Sengstag,
- Federico Simonetta,
- Jürg Steiger,
- Guido Stirniman,
- Ueli Stürzinger,
- Christian Van Delden,
- Jean-Pierre Venetz,
- Jean Villard,
- Julien Vionnet,
- Madeleine Wick,
- Markus Wilhlem,
- Patrick Yerly
Affiliations
- Jakob E. Brune
- Clinic for Transplantation Immunology and Nephrology, University Hospital Basel, Basel, Switzerland
- Michael Dickenmann
- Clinic for Transplantation Immunology and Nephrology, University Hospital Basel, Basel, Switzerland
- Daniel Sidler
- Clinic for Nephrology, Bern University Hospital, Bern, Switzerland
- Laura N. Walti
- Department of Infectious Diseases, Inselspital, Bern University Hospital, Bern, Switzerland
- Déla Golshayan
- Transplantation Center, Lausanne University Hospital, Lausanne, Switzerland
- Oriol Manuel
- Transplantation Center, Lausanne University Hospital, Lausanne, Switzerland
- Oriol Manuel
- Infectious Diseases Service, Lausanne University Hospital, Lausanne, Switzerland
- Fadi Haidar
- Nephrology and Hypertension Service, Division of Medicine, University Hospital Geneva, Geneva, Switzerland
- Dionysios Neofytos
- Transplant Infectious Disease Service, Division of Infectious Diseases, University Hospital Geneva, Geneva, Switzerland
- Aurelia Schnyder
- Clinic for Nephrology, Kantonsspital St. Gallen, St. Gallen, Switzerland
- Katia Boggian
- Division of Infectious Diseases and Hospital Epidemiology, Kantonsspital St. Gallen, St. Gallen, Switzerland
- Thomas F. Mueller
- 0Clinic for Nephrology, University Hospital Zürich, Zürich, Switzerland
- Thomas Schachtner
- 0Clinic for Nephrology, University Hospital Zürich, Zürich, Switzerland
- Nina Khanna
- 1Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland
- Stefan Schaub
- Clinic for Transplantation Immunology and Nephrology, University Hospital Basel, Basel, Switzerland
- Stefan Schaub
- 2Transplantation Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland
- Caroline Wehmeier
- Clinic for Transplantation Immunology and Nephrology, University Hospital Basel, Basel, Switzerland
- the Swiss Transplant Cohort Study
- Patrizia Amico
- John-David Aubert
- Adrian Bachofner
- Vanessa Banz
- Sonja Beckmann
- Guido Beldi
- Christoph Berger
- Ekaterine Berishvili
- Annalisa Berzigotti
- Pierre-Yves Bochud
- Sanda Branca
- Heiner Bucher
- Anne Cairoli
- Emmanuelle Catana
- Yves Chalandon
- Sabina De Geest
- Sophie De Seigneux
- Michael Dickenmann
- Joëlle Lynn Dreifuss
- Michel Duchosal
- Thomas Fehr
- Sylvie Ferrari-Lacraz
- Jaromil Frossard
- Christian Garzoni
- Déla Golshayan
- Nicolas Goossens
- Fadi Haidar
- Jörg Halter
- Dominik Heim
- Christoph Hess
- Sven Hillinger
- Hans Hirsch
- Patricia Hirt
- Linard Hoessly
- Günther Hofbauer
- Uyen Huynh-Do
- Franz Immer
- Michael Koller
- Andreas Kremer
- Christian Kuhn
- Bettina Laesser
- Frédéric Lamoth
- Roger Lehmann
- Alexander Leichtle
- Oriol Manuel
- Hans-Peter Marti
- Michele Martinelli
- Valérie McLin
- Katell Mellac
- Aurélia Merçay
- Karin Mettler
- Nicolas Müller
- Ulrike Müller-Arndt
- Beat Müllhaupt
- Mirjam Nägeli
- Graziano Oldani
- Manuel Pascual
- Jakob Passweg
- Rosemarie Pazeller
- Klara Posfay-Barbe
- David Reineke
- Juliane Rick
- Anne Rosselet
- Simona Rossi
- Rössler
- Silvia Rothlin
- Frank Ruschitzka
- Thomas Schachtner
- Stefan Schaub
- Alexandra Scherrer
- Dominik Schneidawind
- Aurelia Schnyder
- Macé Schuurmans
- Simon Schwab
- Thierry Sengstag
- Federico Simonetta
- Jürg Steiger
- Guido Stirniman
- Ueli Stürzinger
- Christian Van Delden
- Jean-Pierre Venetz
- Jean Villard
- Julien Vionnet
- Madeleine Wick
- Markus Wilhlem
- Patrick Yerly
- DOI
- https://doi.org/10.3389/fmed.2024.1329778
- Journal volume & issue
-
Vol. 11
Abstract
BackgroundEnterobacterales are often responsible for urinary tract infection (UTI) in kidney transplant recipients. Among these, Escherichia coli or Klebsiella species producing extended-spectrum beta-lactamase (ESBL) are emerging. However, there are only scarce data on frequency and impact of ESBL-UTI on transplant outcomes.MethodsWe investigated frequency and impact of first-year UTI events with ESBL Escherichia coli and/or Klebsiella species in a prospective multicenter cohort consisting of 1,482 kidney transplants performed between 2012 and 2017, focusing only on 389 kidney transplants having at least one UTI with Escherichia coli and/or Klebsiella species. The cohort had a median follow-up of four years.ResultsIn total, 139/825 (17%) first-year UTI events in 69/389 (18%) transplant recipients were caused by ESBL-producing strains. Both UTI phenotypes and proportion among all UTI events over time were not different compared with UTI caused by non-ESBL-producing strains. However, hospitalizations in UTI with ESBL-producing strains were more often observed (39% versus 26%, p = 0.04). Transplant recipients with first-year UTI events with an ESBL-producing strain had more frequently recurrent UTI (33% versus 18%, p = 0.02) but there was no significant difference in one-year kidney function as well as longer-term graft and patient survival between patients with and without ESBL-UTI.ConclusionFirst-year UTI events with ESBL-producing Escherichia coli and/or Klebsiella species are associated with a higher need for hospitalization but do neither impact allograft function nor allograft and patient survival.
Keywords
- kidney transplantation
- urinary tract infection
- Enterobacterales
- E. coli
- Klebsiella
- ESBL − extended-spectrum beta-lactamase